Cargando…
Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials
OBJECTIVE: To characterize efficacy, safety/tolerability, and pharmacokinetics of padsevonil (PSL) administered concomitantly with ≤3 antiseizure medications (ASMs) for observable focal seizures in adults with drug‐resistant epilepsy in two multicenter, randomized, double‐blind, placebo‐controlled,...
Autores principales: | Rademacher, Michael, Toledo, Manuel, Van Paesschen, Wim, Liow, Kore K., Milanov, Ivan G., Esch, Maria‐Luise, Wang, Nan, MacPherson, Merran, Byrnes, William J., Minh, Timothy D. C., Webster, Elizabeth, Werhahn, Konrad J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712475/ https://www.ncbi.nlm.nih.gov/pubmed/36176044 http://dx.doi.org/10.1002/epi4.12656 |
Ejemplares similares
-
Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach
por: Muglia, Pierandrea, et al.
Publicado: (2020) -
Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA(A) receptors
por: Niespodziany, Isabelle, et al.
Publicado: (2020) -
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023) -
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
por: de MANREZA, Maria Luiza Giraldes, et al.
Publicado: (2021) -
Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial
por: O’Brien, Terence J., et al.
Publicado: (2022)